Claritas Pharmaceuticals Inc V.CLAS.H

MyKnight makes logical sense on evaluating the value of Kaly

[Donniebrasco57]

RE:Logical KLY SP from a gentlemen on the KLY Facebook group Almost a book, 2 years ago they refused an offer of 1$ a share... Now using the 0.03 cent to evaluate a stock is simply the wrong approach, just to make it simple without writting a book, they look at the Futur revenu that it would bring which is over a billions on year one..... Name one company on the planet that would sell their billions $ company at the price you mentiom? And the licence in europe will be used this year in 2020, and you forgot to mention that they will get the orpheon drug and fast track....which bring the price of phase 3 down and way quicker... You also forgot to mention that they have the monopoly on the planet.... Marketing they don t need marketing when you have 100% rate of success... And saying that no pharma would pay does price show me that you have no clue on what big pharma can do for such a market.... You also forgot to mention that most of the revenu will come from licencing and royalties, so no big infrastructure to maintain no marketing employees as you mention before... Just sale/licence and royalties for the main revenu...in the core.... Good thing that we have echelon negotiating, i m sure that other company have try your approach of evaluating this billions dollar industry..... We will know soon enough.... Well said MyKnight!!! Read more at https://stockhouse.com/companies/bullboard/v.kly/kalytera-therapeutics-inc?postid=30423941#QMm38h1Xr35jW3fR.99